Automated Liquid Handling Technologies Market to Reach US$7.4 Billion by 2034, Driven by AI Integration and Drug Discovery Demand
核心洞察
The global automated liquid handling technologies market is projected to grow from US$2.7 billion in 2024 to US$7.4 billion by 2034 at a CAGR of 10.6%.
Drug discovery and ADME-Tox research accounted for the largest application segment at 41.9% of market share in 2023, with pharmaceutical and biotechnology companies representing 52.3% of end users.
North America leads the market with 39.5% of global revenue, while Asia Pacific is expected to register the fastest growth driven by expanding R&D investments.
The global automated liquid handling technologies market is on track to more than double in value over the next decade, expanding from US$2.7 billion in 2024 to an estimated US$7.4 billion by 2034, representing a compound annual growth rate (CAGR) of 10.6%, according to a market analysis published in July 2026.
Automated liquid handling technologies encompass advanced laboratory systems designed to accurately dispense, transfer, mix, and manage liquid samples with minimal human intervention. These systems have become integral to pharmaceutical, biotechnology, clinical diagnostics, and life sciences workflows by automating repetitive pipetting and sample preparation tasks, thereby reducing manual errors, increasing throughput, and ensuring consistent experimental results.
Drug Discovery Dominates Application Segments
By application, the drug discovery and ADME-Tox research segment held the largest market share at 41.9% in 2023. The segment's dominance reflects the critical role automated liquid handling systems play in accelerating compound screening, improving experimental accuracy, and supporting efficient testing throughout the pharmaceutical research and development process.
Pharmaceutical and biotechnology companies emerged as the leading end-user segment, capturing 52.3% of total market revenue in 2023. Contract research organizations and academic and research institutes represent the remaining significant end-user categories.
In terms of product type, automated liquid handling workstations accounted for 65.2% of the total market share in 2023, with reagents and consumables comprising the balance.
North America Leads, Asia Pacific Accelerates
North America maintained its position as the dominant regional market, accounting for 39.5% of global automated liquid handling technologies revenue in 2023. According to the U.S. National Science Foundation, total U.S. R&D expenditure reached US$892 billion in 2022 and was estimated to increase to US$940 billion in 2023, creating favorable conditions for laboratory automation adoption. The presence of leading industry participants, including Thermo Fisher Scientific (搜索) and Danaher Corporation (搜索), further strengthens regional market growth through continuous innovation and product development.
Asia Pacific is expected to record the highest CAGR during the forecast period, driven by increasing R&D investments, expanding pharmaceutical and biotechnology industries, and improving healthcare infrastructure. Rising research expenditure in countries such as China, Japan, and Australia, coupled with growing demand for high-throughput laboratory technologies, is expected to accelerate adoption across the region.
South Korea Emerges as a Key Growth Market
A separate market analysis focused on South Korea projects the country's automated liquid handling system market to grow from US$23.5 million in 2025 to US$51.0 million by 2036, at a CAGR of 7.47%. The growth is fueled by increasing demands for efficiency, precision, and automation in laboratories, driven by advancements in biotechnology, pharmaceuticals, and clinical research.
Pharmaceutical giants such as Samsung Biologics, Celltrion, and Hanmi Pharmaceutical are expanding their operations, intensifying demand for automated systems to support drug discovery, biomanufacturing, and biotech R&D. The drug discovery application is expected to dominate the South Korean market, while pharmaceutical and biotechnology companies are projected to lead among end users.
Technological Innovation Reshapes the Landscape
The integration of artificial intelligence and machine learning is transforming automated liquid handling systems by improving dispensing accuracy, predicting workflow errors, optimizing protocols, and reducing manual intervention. Cloud-enabled laboratory automation further enhances capabilities through improved data management and remote monitoring.
Additional emerging trends include the growing adoption of miniaturized and compact systems suitable for laboratories with limited infrastructure, expansion into high-throughput screening applications, and increasing demand for modular and customizable platforms that adapt to diverse laboratory workflows. Modern systems increasingly feature intuitive touchscreen interfaces and remote monitoring capabilities that enable real-time performance tracking and faster troubleshooting.
Key market players profiled across the analyses include Agilent Technologies (搜索), Revvity (搜索) (PerkinElmer), Thermo Fisher Scientific (搜索), Danaher Corporation (搜索), Tecan Group (搜索), Eppendorf (搜索), Hamilton Company (搜索), Aurora Biomed, Sartorius (搜索), Opentrons (搜索), SPT Labtech (搜索), Gilson, Integra Biosciences, Haier Biomedical, and Hudson Lab Automation.
Recent industry developments include Beckman Coulter Life Sciences (搜索)' introduction of the Biomek i3 Benchtop Liquid Handler in December 2025, SPT Labtech (搜索) and Alithea Genomics' collaboration on automated single-cell transcriptomics solutions announced in November 2025, and the October 2025 launch of automated target enrichment protocols for SPT Labtech's firefly+ platform developed with Agilent Technologies (搜索).
Challenges and Opportunities
Despite strong growth projections, the market faces challenges including high initial investment and maintenance costs, which present barriers for smaller research institutions and early-stage biotechnology companies. However, the development of standardized, plug-and-play automation workflows for decentralized laboratories represents a significant commercialization opportunity, enabling vendors to reach previously underserved customer segments.
As laboratories continue to prioritize operational efficiency, data accuracy, and regulatory compliance, automated liquid handling technologies are expected to remain an essential component of modern laboratory infrastructure, enabling faster research outcomes and improved productivity across a broad range of scientific and healthcare applications.